OPTICAL COHERENCE TOMOGRAPHY/SURFACE PLASMON RESONANCE: CBORT, BiOptix each attract $1.4M

Two entities working on photonics-based biomedicine have recently attracted funding in the same amount: $1.4 million.

Massachusetts General Hospital (Boston, MA) has received a National Institutes of Health grant totaling $1,449,151 for its Center for Biomedical OCT Research and Translation (CBORT). With CBORT, principal investigator Brett Bouma (a Strategies in Biophotonics advisory board member) aims to bring groundbreaking advances in optical coherence tomography (OCT) to biomedicine. The center seeks to address the deficient accessibility of cutting-edge OCT instrumentation and technology through innovation of new technical capabilities that are motivated by significant biological and clinical challenges, and through translation, facilitated by direct collaboration. Since CBORT's 2011 launch, its members have initiated six driving biomedical projects and have identified technical projects that will have significant biological and clinical impact. The projects fall into three core thematic areas: advanced structural imaging, functional and compositional contrast, and hybrid imaging modalities.

Colorado-based optical biodetection company BiOptix (Boulder) reports that it has received an additional $1.4 million from investors, which they will use to expand sales and marketing and ramp up manufacturing to meet growing customer demand. The company sees opportunity in the label-free marketplace, which CEO Rick Whitcomb says is looking for a reasonably priced high-performance surface plasmon resonance (SPR) instrument. They have developed and patented an ultra-sensitive detection platform known as Enhanced Surface Plasmon Resonance (ESPR), which pairs the high sensitivity of SPR with the high stability and lower noise of common-path interferometry.

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

FDA authorizes emergency use of Zika virus molecular detection assay

The xMAP MultiFLEX Zika RNA assay combines optofluidics and digital signal processing to detect Zika virus in vitro.

Merz acquires laser tattoo removal device maker ON Light Sciences

Merz North America has acquired ON Light Sciences, which develops technologies to enhance laser-based dermatology procedures.

Shortwave-infrared device could improve ear infection diagnosis

An otoscope-like device that could improve ear infection diagnosis uses shortwave-infrared light instead of visible light.

Laser therapy extracts rare tumor that grew human hair, skin in boy's skull

About four years ago, a tumor comprised of human skin, hair, bone and cartilage was fast-growing inside a Ramsey, MN, 10-year-old youth's brain.
BLOGS

Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...

CONNECT WITH US

            

Twitter- BioOptics World

Copyright © 2007-2016. PennWell Corporation, Tulsa, OK. All Rights Reserved.PRIVACY POLICY | TERMS AND CONDITIONS